Showing results (571-580 of 604) with videos related to
Sort By:
Pageof 61
Rheumatology (Oxford, England)|September 10, 2015
Systemic inflammatory and autoimmune manifestations associated with myelodysplastic syndromes and chronic myelomonocytic leukaemia: a French multicentre retrospective studyArsène Mekinian, Eric Grignano, Thorsten Braun, et al.Annals of the Rheumatic Diseases|June 17, 2010
Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) databaseAnthony J Tyndall, Bettina Bannert, Madelon Vonk, et al.Ebiomedicine|April 3, 2026
Exome sequencing enables molecular diagnosis in 10% of early-onset or familial systemic lupus erythematosus casesMaud Tusseau, Samira Khaldi-Plassart, Audrey Labalme, et al.Respiratory Medicine and Research|December 24, 2022
2022 Update of indications and contraindications for lung transplantation in FranceJérôme Le Pavec, Christophe Pison, Sandrine Hirschi, et al.Annals of the Rheumatic Diseases|March 19, 2017
Transethnic meta-analysis identifies GSDMA and PRDM1 as susceptibility genes to systemic sclerosisChikashi Terao, Takahisa Kawaguchi, Philippe Dieude, et al.The Lancet. Rheumatology|June 15, 2024
Prevalence and target attainment of traditional cardiovascular risk factors in patients with systemic lupus erythematosus: a cross-sectional study including 3401 individuals from 24 countriesEleana Bolla, Anne Grete Semb, Anne M Kerola, et al.Clinical and Experimental Rheumatology|May 19, 2011
Is there a role for TNFα antagonists in the treatment of SSc? EUSTAR expert consensus development using the Delphi techniqueJoerg H W Distler, Suzana Jordan, Paolo Airo, et al.Clinical and Experimental Rheumatology|March 14, 2023
ERN ReCONNET points to consider for treating patients living with autoimmune rheumatic diseases with antiviral therapies and anti-SARS-CoV-2 antibody productsRosaria Talarico, Giuseppe Alvise Ramirez, Sofia C Barreira, et al.RMD Open|September 13, 2022
Factors associated with severe COVID-19 in people with idiopathic inflammatory myopathy: results from the COVID-19 Global Rheumatology Alliance physician-reported registrySu-Ann Yeoh, Milena Gianfrancesco, Saskia Lawson-Tovey, et al.Clinical and Experimental Rheumatology|May 17, 2022
Venous thromboembolism during systemic inflammatory and autoimmune diseases associated with myelodysplastic syndromes, chronic myelomonocytic leukaemia and myelodysplastic/myeloproliferative neoplasms: a French multicentre retrospective case-control studyMarie Péan de Ponfilly-Sotier, Vincent Jachiet, Ygal Benhamou, et al.Pageof 61